Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Carcinoma, Non-small-cell Lung

Thank you

Trial Information


Inclusion Criteria:



- Histologic or cytologic diagnosis of non-small cell lung carcinoma

- Progressed while on or after treatment on platinum-based regimen

- Patients may not have had more than one prior cytotoxic chemotherapy regimen

- Stage IV or IIIB

- Age at least 18 years

- Adequate liver and kidney function

- Adequate bone marrow function

Exclusion Criteria:

- Pregnancy or lactation

- Unstable medical conditions

- Chemotherapy, hormonal therapy, radiotherapy, radiopharmaceuticals or immunotherapy
within 3 weeks of TLK286

- CNS metastasis unless controlled by treatment

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

TLK286.2014

NCT ID:

NCT00040638

Start Date:

July 2002

Completion Date:

August 2003

Related Keywords:

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung

Name

Location

Arizona Cancer CenterTucson, Arizona  85724
UCLA Medical CenterLos Angeles, California  90095-7059
M.D. Anderson Cancer CenterHouston, Texas  77030